Akèy › Atrit psoryatik › Georgia
Etid klinik pou Atrit psoryatik nan Georgia
7 etid pou Atrit psoryatik ap chèche patisipan nan sit nan Georgia.
Tèks ofisyèl etid la (Anglè)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
Ap rekriteFaz 3
Laj 3 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Atlanta Research Center for Rheumatology, Marietta
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07321873A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Marietta Rheumatology Associates, Marietta
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Gainesville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- North Georgia Rheumatology Group PC, Lawrenceville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06671496Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Emory Children's Center, Atlanta
- Georgia Regents University Medical Center, Augusta
Ap rekriteEtid obsèvasyon
Jiska laj 21 · Tout sèks · Mizajou Aug 27, 2026 · NCT02418442Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Parris and Associates, Lilburn
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Oct 9, 2025 · NCT05669833Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.